Laurence Wild has extensive experience in market access, currently serving in a role focused on global pricing and market access within the oncology division at AstraZeneca. Prior to this, Laurence held the position of Director of International Market Access at Vertex Pharmaceuticals from 2019 to 2022 and worked in UK and EMEA market access at Gilead Sciences from 2013 to 2019. Before entering the pharmaceutical industry, Laurence was involved in global pricing and market access consultancies such as IMS (now IQVIA), Double Helix (McCann), and Ashfield from 2009 to 2013. Laurence earned a PhD in Epigenetics, Bioinformatics, and Oncology from UCL and a first-class MA in Natural Sciences from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices